ACS Comments on Importation of Pharmaceutical Products

In response to a Department of Commerce request, ACS CAN submitted comments on the role of pharmaceutical products manufactured outside of the U.S. and the potential impacts that tariffs could have on the availability of generic sterile injectable drugs needed by patients with cancer.